Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MTOR Inhibitors”

613 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 613 results

Testing effectiveness (Phase 2)Study completedNCT01016015
What this trial is testing

Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Metastatic OsteosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 178
Testing effectiveness (Phase 2)Study completedNCT01281917
What this trial is testing

Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
University of Wisconsin, Madison 40
Testing effectiveness (Phase 2)Study completedNCT00378703
What this trial is testing

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 361
Testing effectiveness (Phase 2)Study completedNCT01051557
What this trial is testing

Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)UnknownNCT01614301
What this trial is testing

Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma

Who this might be right for
Advanced Melanoma
University of Regensburg 136
Not applicableStudy completedNCT03730428
What this trial is testing

Everolimus Related Pneumonitis in MBC

Who this might be right for
EverolimusPneumonitis
Fudan University 86
Post-approval studies (Phase 4)Study completedNCT02328963
What this trial is testing

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

Who this might be right for
Transplantation InfectionCytomegalovirus Infection
University Hospital, Bordeaux 186
Testing effectiveness (Phase 2)Study completedNCT02093598
What this trial is testing

POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus

Who this might be right for
Carcinoma, EndometrioidmTOR Protein
MedSIR 10
Not applicableUnknownNCT03716011
What this trial is testing

A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT

Who this might be right for
Coronary Artery Disease
JW Medical Systems Ltd 2,700
Early research (Phase 1)Study completedNCT00993499
What this trial is testing

Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 44
Early research (Phase 1)Looking for participantsNCT06528301
What this trial is testing

UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Who this might be right for
Lymphoma, B-CellLymphoma, Non-Hodgkin (NHL)Lymphoma, Large B-Cell, Diffuse (DLBCL)+1 more
Umoja Biopharma 106
Large-scale testing (Phase 3)Active Not RecruitingNCT04582136
What this trial is testing

Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Chinese SLE Treatment And Research Group 146
Not applicableActive Not RecruitingNCT04562532
What this trial is testing

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

Who this might be right for
Coronary Artery Disease
Shanghai MicroPort Medical (Group) Co., Ltd. 1,720
Testing effectiveness (Phase 2)Study completedNCT00290472
What this trial is testing

CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueMalignant Neoplasm+15 more
National Cancer Institute (NCI) 89
Post-approval studies (Phase 4)Study completedNCT00552669
What this trial is testing

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents

Who this might be right for
Coronary Heart DiseaseCoronary Restenosis
Centro de estudios en Cardiologia Intervencionista 200
Testing effectiveness (Phase 2)Study completedNCT00304954
What this trial is testing

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
National Eye Institute (NEI) 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07436611
What this trial is testing

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

Who this might be right for
Port Wine Stains
AFT Pharmaceuticals, Ltd. 30
Early research (Phase 1)Study completedNCT00874562
What this trial is testing

Rapamycin in Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 6
Testing effectiveness (Phase 2)WithdrawnNCT02365415
What this trial is testing

Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement

Who this might be right for
Peripheral Pulmonary StenosisIn-stent Stenosis
Boston Children's Hospital
Testing effectiveness (Phase 2)Study completedNCT00711490
What this trial is testing

Sirolimus to Treat Diabetic Macular Edema

Who this might be right for
Diabetic Retinopathy
National Eye Institute (NEI) 5
Load More Results